A combination of both GLP-1 medications and exercise were needed to achieve weight loss without also losing bone density, researchers found.
Researchers say the sudden metabolic and caloric weight loss caused by Ozempic, combined with direct effects the drug has on brain functions may cause impulse control disorders.
Findings align with warnings issued by anesthesiologists last summer about Ozempic aspiration risks, following reports of life-threatening problems caused by delayed gastric emptying during surgery.
Death reports linked to Ozempic and similar drugs indicate users suffered from intestinal masses, stomach paralysis, pancreatic cancer and seizures.
FDA approved expanded use of Wegovy for cardiovascular disease caused by being overweight, as concerns continue to grow about reports of stomach paralysis injuries some users are experiencing.
Drug maker plans to pursue legal remedies against compounding pharmacies, medical spas and other entities that claim to sell generic versions of Mounjaro and Zepbound.
New York woman indicates she had to undergo an emergency resection of her bowels and now needs to use a colostomy bag as a result of gastroparesis and intestinal obstructions from Mounjaro
Researchers noted that side effects of Ozempic and similar drugs were particularly linked to an increased risk in eating disorders, such as self-induced vomiting and fear of eating.
The New Jersey production facility has a history or quality control problems over the last several years, according to FDA records.
The agency notes it has not completely ruled out the suicide risk, and it is continuing to investigate the potential side effects of Ozempic, Wegovy, Mounjaro and similar diabetes or weight loss drugs.
